EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth

Henri Tuurala, Janna Waltimo-Sirén, Helena Valta, Heidi Arponen

Calcified Tissue International · 2026

DOI: 10.1007/s00223-025-01476-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Calcified Tissue International, 2026. Verfasst von Henri Tuurala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Dentistry and Orthodontics, University of Turku, FI-20520, Turku, Finland. hmatuu@utu.fi. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Diphosphonates, Skull, Bone Density Conservation Agents. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Turku.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteogenesis imperfecta is a rare hereditary condition affecting type 1 collagen formation. Among the wide spectrum of phenotypic features, osteogenesis imperfecta variably impairs craniofacial growth, affecting facial morphology and predisposing to malocclusion. At present, bisphosphonates are the gold standard for treatment of osteogenesis imperfecta, but knowledge on the effect of the medication on craniofacial growth is lacking. This retrospective study analysed lateral skull radiographs of 36 growing individuals with osteogenesis imperfecta and bisphosphonate treatment history (mean age 10.0 years, 13 females). Of them, 23 had been diagnosed with type I, 8 with type III, and 5 with type IV osteogenesis imperfecta. The historical control group that had not received bisphosphonate therapy comprised 34 individuals (mean age 8.1 years, 22 females) with osteogenesis imperfecta, type I in 18, type III in 7, and type IV in 9 individuals. The cephalometric measurement values were converted into age- and sex-matched Z-scores based on normal population values of the same ethnicity. Inter-group comparisons of the Z-scores showed several statistically significant differences where the bisphosphonate treatment group deviated less from unaffected population than the historical group. These included one or more of the mandibular size measurements in all studied types of osteogenesis imperfecta, anterior facial height and maxillary length in type IV, as well as cranial base angle, posterior facial height and angulation between the jaws in type III. Our findings suggest that bisphosphonate therapy may positively enhance both mid-facial and mandibular craniofacial growth in individuals with osteogenesis imperfecta.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaDiphosphonatesSkullBone Density Conservation AgentsHumansFemaleCephalometryRetrospective StudiesChildMaleAdolescentChild, Preschool

Stichwörter der Autor:innen

Bisphosphonate therapyCephalometric analysisCraniofacial developmentGrowthOsteogenesis imperfecta

Substanzen

DiphosphonatesBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Pediatric Dentistry and Orthodontics, University of Turku, FI-20520, Turku, Finland. hmatuu@utu.fi.
  • Department of Pediatric Dentistry and Orthodontics, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, FI-20520, Turku, Finland. hmatuu@utu.fi.
  • Department of Pediatric Dentistry and Orthodontics, University of Turku, FI-20520, Turku, Finland.
  • Wellbeing Services County of South-West Finland, FI-20520, Turku, Finland.
  • Pediatric Research Centre, Children's Hospital, University of Helsinki and Helsinki University Hospital, FI-00290, Helsinki, Finland.
  • Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, FI-00290, Helsinki, Finland.

Förderung

  • University of Turku

Zitieren

APA

Tuurala, H., Waltimo-Sirén, J., Valta, H., & Arponen, H. (2026). In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth. Calcified Tissue International. https://doi.org/10.1007/s00223-025-01476-5

Vancouver

Tuurala H, Waltimo-Sirén J, Valta H, Arponen H. In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth. Calcified Tissue International. 2026. doi:10.1007/s00223-025-01476-5

BibTeX
@article{Tuurala2026,
  author = {Tuurala, Henri and Waltimo-Sirén, Janna and Valta, Helena and Arponen, Heidi},
  title = {In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth},
  journal = {Calcified Tissue International},
  year = {2026},
  doi = {10.1007/s00223-025-01476-5}
}
Kostenlos starten →